Your browser doesn't support javascript.
loading
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.
Tuschl, Karin; Meyer, Esther; Valdivia, Leonardo E; Zhao, Ningning; Dadswell, Chris; Abdul-Sada, Alaa; Hung, Christina Y; Simpson, Michael A; Chong, W K; Jacques, Thomas S; Woltjer, Randy L; Eaton, Simon; Gregory, Allison; Sanford, Lynn; Kara, Eleanna; Houlden, Henry; Cuno, Stephan M; Prokisch, Holger; Valletta, Lorella; Tiranti, Valeria; Younis, Rasha; Maher, Eamonn R; Spencer, John; Straatman-Iwanowska, Ania; Gissen, Paul; Selim, Laila A M; Pintos-Morell, Guillem; Coroleu-Lletget, Wifredo; Mohammad, Shekeeb S; Yoganathan, Sangeetha; Dale, Russell C; Thomas, Maya; Rihel, Jason; Bodamer, Olaf A; Enns, Caroline A; Hayflick, Susan J; Clayton, Peter T; Mills, Philippa B; Kurian, Manju A; Wilson, Stephen W.
Afiliação
  • Tuschl K; Genetics and Genomic Medicine, UCL Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Meyer E; Department of Cell and Developmental Biology, University College London, London WC1E 6BT, UK.
  • Valdivia LE; Developmental Neurosciences, UCL Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Zhao N; Department of Cell and Developmental Biology, University College London, London WC1E 6BT, UK.
  • Dadswell C; Department of Cell, Development and Cancer Biology, Oregon Health &Sciences University, Portland, Oregon 97239, USA.
  • Abdul-Sada A; Department of Chemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, UK.
  • Hung CY; Department of Chemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, UK.
  • Simpson MA; Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Chong WK; Division of Genetics and Molecular Medicine, King's College London School of Medicine, London SE1 9RT, UK.
  • Jacques TS; Department of Radiology, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.
  • Woltjer RL; Developmental Biology and Cancer, UCL Institute of Child Health and Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.
  • Eaton S; Department of Pathology, Oregon Health &Science University, Portland, Oregon 97239, USA.
  • Gregory A; Developmental Biology and Cancer Programme, UCL Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Sanford L; Department of Molecular &Medical Genetics, Oregon Health &Science University, Portland, Oregon 97239, USA.
  • Kara E; Department of Molecular &Medical Genetics, Oregon Health &Science University, Portland, Oregon 97239, USA.
  • Houlden H; Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Cuno SM; Alzheimer's Disease Research Centre, Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
  • Prokisch H; Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Valletta L; Institute of Human Genetics, Technische Universität München, Munich 81675, Germany.
  • Tiranti V; Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany.
  • Younis R; Institute of Human Genetics, Technische Universität München, Munich 81675, Germany.
  • Maher ER; Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany.
  • Spencer J; Unit of Molecular Neurogenetics, IRCCS, Foundation Neurological Institute 'C. Besta', Milan 20133, Italy.
  • Straatman-Iwanowska A; Unit of Molecular Neurogenetics, IRCCS, Foundation Neurological Institute 'C. Besta', Milan 20133, Italy.
  • Gissen P; Department of Medical and Molecular Genetics, University of Birmingham, Birmingham B15 2TT, UK.
  • Selim LA; Centre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Pintos-Morell G; Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, and Cambridge NIHR Biomedical Research Centre, Cambridge CB2 0QQ, UK.
  • Coroleu-Lletget W; Department of Chemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, UK.
  • Mohammad SS; MRC Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London WC1E 6BT, UK.
  • Yoganathan S; Genetics and Genomic Medicine, UCL Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Dale RC; MRC Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London WC1E 6BT, UK.
  • Thomas M; Department of Metabolic Medicine, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.
  • Rihel J; Department of Paediatric Neurology, Faculty of Medicine, Cairo University Children's Hospital, Cairo 11432, Egypt.
  • Bodamer OA; Department of Paediatrics, Section of Paediatric Nephrology, Genetics and Metabolism, Unit of Rare Diseases, University Hospital 'Germans Trias I Pujol', Universitat Autònoma de Barcelona, Badalona 08916, Spain.
  • Enns CA; Department of Paediatrics, Paediatric Neurology and Neonatology Unit, University Hospital 'Germans Trias I Pujol', Badalona 08916, Spain.
  • Hayflick SJ; Neuroimmunology Group, Institute for Neuroscience and Muscle Research, Kids Research Institute at the Children's Hospital at Westmead, University of Sydney, Westmead NSW 2145, Australia.
  • Clayton PT; Department of Neurological Sciences, Christian Medical College Hospital, Vellore 632 004, India.
  • Mills PB; Neuroimmunology Group, Institute for Neuroscience and Muscle Research, Kids Research Institute at the Children's Hospital at Westmead, University of Sydney, Westmead NSW 2145, Australia.
  • Kurian MA; Department of Neurological Sciences, Christian Medical College Hospital, Vellore 632 004, India.
  • Wilson SW; Department of Cell and Developmental Biology, University College London, London WC1E 6BT, UK.
Nat Commun ; 7: 11601, 2016 05 27.
Article em En | MEDLINE | ID: mdl-27231142
Although manganese is an essential trace metal, little is known about its transport and homeostatic regulation. Here we have identified a cohort of patients with a novel autosomal recessive manganese transporter defect caused by mutations in SLC39A14. Excessive accumulation of manganese in these patients results in rapidly progressive childhood-onset parkinsonism-dystonia with distinctive brain magnetic resonance imaging appearances and neurodegenerative features on post-mortem examination. We show that mutations in SLC39A14 impair manganese transport in vitro and lead to manganese dyshomeostasis and altered locomotor activity in zebrafish with CRISPR-induced slc39a14 null mutations. Chelation with disodium calcium edetate lowers blood manganese levels in patients and can lead to striking clinical improvement. Our results demonstrate that SLC39A14 functions as a pivotal manganese transporter in vertebrates.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Distúrbios Distônicos / Proteínas de Transporte de Cátions / Homeostase / Manganês / Mutação Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Distúrbios Distônicos / Proteínas de Transporte de Cátions / Homeostase / Manganês / Mutação Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido